Literature DB >> 24307478

Is it safe to withdraw etanercept in established rheumatoid arthritis after low disease activity achievement?

Roberta Gualtierotti1, Francesco Casella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24307478     DOI： 10.1007/s11739-013-1024-9

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

Review 1.  Rheumatoid arthritis.

Authors:  David L Scott; Frederick Wolfe; Tom W J Huizinga
Journal:  Lancet       Date:  2010-09-25       Impact factor: 79.321

Review 2.  Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis.

Authors:  Gianluca Furneri; Lorenzo G Mantovani; Andrea Belisari; Marta Mosca; Marco Cristiani; Stefania Bellelli; Paolo A Cortesi; Giuseppe Turchetti
Journal:  Clin Exp Rheumatol       Date:  2012-10-22       Impact factor: 4.473

Review 3.  2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.

Authors:  Jasvinder A Singh; Daniel E Furst; Aseem Bharat; Jeffrey R Curtis; Arthur F Kavanaugh; Joel M Kremer; Larry W Moreland; James O'Dell; Kevin L Winthrop; Timothy Beukelman; S Louis Bridges; W Winn Chatham; Harold E Paulus; Maria Suarez-Almazor; Claire Bombardier; Maxime Dougados; Dinesh Khanna; Charles M King; Amye L Leong; Eric L Matteson; John T Schousboe; Eileen Moynihan; Karen S Kolba; Archana Jain; Elizabeth R Volkmann; Harsh Agrawal; Sangmee Bae; Amy S Mudano; Nivedita M Patkar; Kenneth G Saag
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

Review 4.  Overview of safety of non-biologic and biologic DMARDs.

Authors:  Eric M Ruderman
Journal:  Rheumatology (Oxford)       Date:  2012-12       Impact factor: 7.580

5.  Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.

Authors:  Josef S Smolen; Peter Nash; Patrick Durez; Stephen Hall; Elena Ilivanova; Fedra Irazoque-Palazuelos; Pedro Miranda; Min-Chan Park; Karel Pavelka; Ronald Pedersen; Annette Szumski; Constance Hammond; Andrew S Koenig; Bonnie Vlahos
Journal:  Lancet       Date:  2013-01-17       Impact factor: 79.321
  5 in total
  2 in total

1.  The challenge of using the rheumatoid arthritis diagnostic criteria in clinical practice.

Authors:  Salvatore Corrao; Christiano Argano; Luigi Calvo; Giovanni Pistone
Journal:  Intern Emerg Med       Date:  2015-02-12       Impact factor: 3.397

2.  Single-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment.

Authors:  Louis Bessette; Majed Khraishi; Alan J Kivitz; Arunan Kaliyaperumal; Rama Grantab; Melanie Poulin-Costello; Maya Isaila; David Collier
Journal:  Rheumatol Ther       Date:  2017-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.